French Gynecologist’s “Real Women” Remark Fuels Debate as Trans Patient Case Heads to Appeal
A French gynecologist’s refusal to examine a transgender woman did more than end an appointment before it began. It triggered complaints, disciplinary action, a criminal prosecution and a fierce argument over where medical expertise ends, and discrimination begins.
At the center of the controversy was a 26-year-old transgender woman who had reportedly been receiving hormone treatment for about three years. She booked an appointment because she was experiencing breast pain and was concerned about a lump.
An Appointment That Ended in the Waiting Room
The patient arrived at Acharian’s office with her partner after arranging the visit online. According to accounts presented in court, the doctor learned through his secretary that the patient was transgender and had not undergone genital surgery.
The woman was then informed that Acharian would not see her. The gynecologist later said he lacked the necessary experience and intended to direct her to another specialist.
“I told her that I’m not competent, but I can guide you,” Acharian told Euronews shortly after the incident. “I can refer you to services that can better take care of you.”
He also acknowledged that he had never treated a transgender woman during roughly three decades of medical practice.
The encounter quickly became heated. The woman left the office without being examined, and her partner later posted a negative Google review accusing the clinic of turning her away.
That was when the dispute moved from a private medical office to the public internet.
Responding to the review, Acharian wrote that he treated “real women” and had no competence to care for men, “even if they have shaved their beards and come to tell my secretary that they have become women.” He also thanked the reviewer for warning other transgender people not to visit his clinic.
The wording transformed what might have remained a disagreement over specialist care into a much larger controversy about dignity, professional conduct and transgender access to health services.
Acharian later admitted that his response was inappropriate.
“I reacted spontaneously, out of anger, and I felt I’d been unfairly attacked,” he told Euronews. He described the language as “very clumsy” and said he had expressed regret several times.
The Court Delivered a Divided Verdict
LGBTQ+ organizations filed complaints over the incident, while the patient pursued the matter through France’s medical and legal systems.
A disciplinary body within the French Medical Council eventually imposed a six-month ban from practicing, with one month to be served and the remaining five months suspended. The sanction recognized professional misconduct connected to the way the patient was treated and the doctor’s public remarks.
During the hearing, Acharian maintained that he had refused the consultation because he lacked suitable training. He told the court that he had never examined breast tissue developed by someone who had been taking feminizing hormones for three years and said he had planned to recommend a more appropriate specialist.
He also apologized again for his internet response, calling it “clumsy and dishonorable.”
Prosecutor Orlane Yaouanq took a sharply different view. She described the online comment as crude and argued that the refusal was “purely discriminatory.” Prosecutors requested a six-month suspended prison sentence and a fine.
The court did not accept the full prosecution case.
Judges acquitted Acharian of criminal discrimination connected to the refusal to provide the consultation. However, they found him guilty of a sexist and sexual insult aggravated by the victim’s gender identity and imposed a suspended fine of €1,000.
The distinction mattered. The court did not rule that every decision to refer a transgender patient elsewhere is automatically discriminatory. It did, however, determine that Acharian’s public language crossed a legal line.
The dispute did not end there. French prosecutors appealed the acquittal, meaning Acharian would again have to defend his conduct before an appeals court. No later appeal judgment was identified in the publicly available reports reviewed for this article.
Why the Case Became Bigger Than One Doctor
The case exposed a genuine tension within modern medicine.
Doctors are not expected to perform procedures for which they lack training. A specialist may sometimes refer a patient when the requested care falls outside the doctor’s field. Yet professional authorities say that referrals must be handled respectfully, without discrimination and with appropriate continuity of care.
France’s National Medical Council stated in November 2024 that doctors have a professional duty to care for transgender patients without discrimination.
“The doctor listens, examines, advises and treats every person with the same conscience,” the council said, adding that physicians must always maintain a correct and attentive attitude.
Medical experts have also noted that transgender patients do not all require the same services.
Pernille Ravn, a gynecologist at Denmark’s Odense University Hospital and a member of the European Society of Gynecology, told Euronews that transgender women without a uterus or cervix generally do not require routine gynecological screening. However, she said some may experience complications following gender-affirming surgery that require assessment by a properly trained specialist.
In this case, the patient’s stated concern involved breast pain and a possible lump, rather than a routine examination of reproductive organs. That detail became central to arguments over whether Acharian should at least have assessed her symptoms before making a referral.
France has since taken steps to clarify medical expectations. In July, the country’s Haute Autorité de Santé published national practice guidelines aimed at improving health care for transgender adults. The recommendations cover hormone treatment, surgery, psychological support and ordinary medical care.
Those guidelines do not mean every doctor must possess expertise in every aspect of transgender medicine. They do reinforce a broader principle: transgender patients have the same basic entitlement to respectful, competent health care as anyone else.
That is why the debate surrounding Acharian has endured. His defenders focus on a doctor’s right to acknowledge the limits of his training. His critics focus on the humiliating language, the lack of an examination and the risk that vulnerable patients may avoid seeking care after being turned away.
The case ultimately became about more than who belongs on a gynecologist’s examination table. It raised a harder question for health systems everywhere: when a doctor lacks specialized knowledge, how should that limitation be communicated without denying the patient dignity or access to care?
France’s courts may still provide another legal answer. The medical lesson is already becoming clearer. A referral can be clinical, but respect is not a specialty.
